APA

Lamb L. S., Abhyankar S. A., Hazlett L., O'Neal W., Folk R. S., Vogt S., Parrish R. S., Bridges K., Henslee-Downey P. J. & Gee A. P. (19991118). Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease. : Cytometry.

Chicago

Lamb L S, Abhyankar S A, Hazlett L, O'Neal W, Folk R S, Vogt S, Parrish R S, Bridges K, Henslee-Downey P J and Gee A P. 19991118. Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease. : Cytometry.

Harvard

Lamb L. S., Abhyankar S. A., Hazlett L., O'Neal W., Folk R. S., Vogt S., Parrish R. S., Bridges K., Henslee-Downey P. J. and Gee A. P. (19991118). Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease. : Cytometry.

MLA

Lamb L S, Abhyankar S A, Hazlett L, O'Neal W, Folk R S, Vogt S, Parrish R S, Bridges K, Henslee-Downey P J and Gee A P. Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease. : Cytometry. 19991118.